China will formally establish a blacklist system of commercial bribery in the purchase and sale of Medicine

2013-12-27 source: according to the news and newspaper summary of voice of China, the national health and Family Planning Commission said that it would officially establish a blacklist system for commercial bribery of pharmaceutical purchase and sale, and pharmaceutical manufacturers and medical staff with bad records would be severely punished Cui Li, deputy director of the national health and Family Planning Commission, said the revised and improved regulations on bad records of commercial bribery in the field of medicine purchase and sale will come into effect on March 1 next year The pharmaceutical manufacturers listed in the bad records of commercial bribery will be severely punished: for those listed in the bad records of commercial bribery twice or more within five years, all public medical institutions or medical and health institutions receiving financial funds shall not purchase their drugs, medical equipment and medical consumables within two years Cui Li said that the medical staff who accept bribes will also be punished by confiscating their illegal earnings and revoking their practice certificates in accordance with the regulations If a person in charge of a medical institution, a drug purchaser, a doctor or other relevant personnel receives money, property or other benefits from a pharmaceutical production and marketing enterprise or its agent, the illegal income shall be confiscated If the case is serious, the practicing doctor shall be revoked by the health and family planning administrative department If the case constitutes a crime, criminal responsibility shall be investigated according to law